Genpact Limited (NYSE:G – Get Free Report) SVP Piyush Mehta sold 200,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $43.05, for a total transaction of $8,610,000.00. Following the transaction, the senior vice president directly owned 156,823 shares of the company’s stock, valued at $6,751,230.15. The trade was a 56.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Genpact Stock Performance
Genpact stock traded up $0.54 during midday trading on Friday, reaching $43.67. 2,444,134 shares of the company traded hands, compared to its average volume of 2,396,008. Genpact Limited has a 12 month low of $26.85 and a 12 month high of $48.64. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.95 and a quick ratio of 2.00. The business has a 50 day moving average of $36.96 and a two-hundred day moving average of $35.47. The firm has a market capitalization of $7.30 billion, a price-to-earnings ratio of 12.73, a price-to-earnings-growth ratio of 1.16 and a beta of 0.53.
Genpact (NYSE:G – Get Free Report) last posted its earnings results on Thursday, November 5th. The business services provider reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.03. Genpact had a net margin of 11.04% and a return on equity of 23.02%. The business’s revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.97 earnings per share. As a group, research analysts predict that Genpact Limited will post 3.66 earnings per share for the current year.
Genpact Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 23rd. Stockholders of record on Thursday, December 10th will be paid a $0.1875 dividend. This represents a $0.75 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Thursday, December 10th. Genpact’s dividend payout ratio (DPR) is 21.87%.
Analyst Ratings Changes
G has been the topic of a number of recent research reports. JPMorgan Chase & Co. increased their target price on Genpact from $40.00 to $45.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Wall Street Zen downgraded Genpact from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Weiss Ratings raised shares of Genpact from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, October 14th. TD Cowen upped their price target on shares of Genpact from $42.00 to $43.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Finally, Citigroup increased their price objective on shares of Genpact from $36.00 to $44.00 and gave the stock a “neutral” rating in a research note on Monday. Two research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $41.89.
Key Stories Impacting Genpact
Investors following G have been watching these stories:
- Positive Sentiment: Mars has opened a global capability center in Hyderabad in collaboration with Genpact and plans to grow the workforce there to 1,000. The project points to continued client demand and potential for expanded services. Mars opens GCC in Hyderabad with Genpact, plans to scale workforce to 1,000
- Neutral Sentiment: Genpact’s new survey found that while 79% of enterprises have AI agents in production, only 15% have tied AI investment to profit-and-loss outcomes. This highlights a significant opportunity for Genpact’s operations expertise, but also shows that converting AI adoption into measurable business value remains a challenge. Genpact report on AI agents and business value
- Negative Sentiment: Senior Vice President Piyush Mehta sold 200,000 shares for about $8.61 million, cutting his direct holdings by 56.05%. The large insider sale could raise concerns, although it does not by itself indicate a change in the company’s outlook. SEC filing for Piyush Mehta share sale
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of G. Dimensional Fund Advisors LP raised its stake in Genpact by 12.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,609,641 shares of the business services provider’s stock valued at $208,965,000 after purchasing an additional 598,877 shares during the period. Pzena Investment Management LLC grew its holdings in Genpact by 10.9% during the 3rd quarter. Pzena Investment Management LLC now owns 3,682,880 shares of the business services provider’s stock valued at $119,804,000 after buying an additional 363,334 shares in the last quarter. First Trust Advisors LP grew its holdings in Genpact by 15.2% during the 3rd quarter. First Trust Advisors LP now owns 3,306,215 shares of the business services provider’s stock valued at $107,551,000 after buying an additional 437,236 shares in the last quarter. Temasek Holdings Private Ltd purchased a new stake in Genpact during the 1st quarter valued at approximately $30,037,000. Finally, Pacer Advisors Inc. raised its position in shares of Genpact by 40.7% during the first quarter. Pacer Advisors Inc. now owns 765,204 shares of the business services provider’s stock valued at $28,504,000 after buying an additional 221,536 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.
About Genpact
Genpact is a global professional services company that helps businesses improve operations and pursue digital transformation. Its services include business process management, consulting, data and analytics, artificial intelligence, and technology implementation. The company works with clients across industries such as banking and financial services, insurance, consumer goods, healthcare, life sciences, manufacturing, and technology. It serves organizations around the world through its global operations.
Featured Articles
- Five stocks we like better than Genpact
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
